Back to 
Renaissance Technologies LLC
Renaissance Technologies LLC
DRUG
Showing 2 of 4 quarters
Position history for Renaissance Technologies LLC's holdings in Bright Minds Biosciences Inc.
No. Renaissance Technologies exited its DRUG (Bright Minds Biosciences) position in Q4 2025. Its Q3 2025 13F listed 3,500 shares worth $212,310. Renaissance Technologies first reported DRUG in Q4 2023 and held it in 2 quarterly 13F filings.
Final Value
$0
Final Shares
0
Total Value Change
-$212,310
Total Shares Change
-3,500
Quarter-by-Quarter History
Other major holders of DRUG: Jupiter Topco LLC, Janus Henderson Group Ltd., BlackRock, Inc.